Gene fusion characterisation of rare aggressive prostate cancer variants—adenosquamous carcinoma, pleomorphic giant‐cell carcinoma, and sarcomatoid carcinoma: an analysis of 19 cases
Sean R. Williamson(Cleveland Clinic), Lisa J. Whiteley(Henry Ford Health System), Kiril Trpkov(University of Calgary), Ioan Tudor Vladislav(Henry Ford Health System), Dhananjay Chitale(Henry Ford Hospital), Yuan Gao(St. John’s Health Sciences Centre), Juan C. Gomez-Gelvez(Memorial Sloan Kettering Cancer Center), Nallasivam Palanisamy(Henry Ford Health System), Ondřej Hes(Charles University), Laura Favazza(Henry Ford Health System), Michael Ittmann(Baylor College of Medicine), Ali M. Alani(Baylor College of Medicine), Steven C. Smith(Virginia Commonwealth University), Nicole D. Riddle, Liang Cheng(Brown University), Nilesh Gupta(Henry Ford Health System), Shannon Carskadon(Henry Ford Health System)
Cited by 25
Related Papers
The Banff 97 working classification of renal allograft pathology
|Kidney International|1999|3.1k
Antibody-Mediated Rejection Criteria - an Addition to the Banff ’97 Classification of Renal Allograft Rejection
|American Journal of Transplantation|2003|1.1k
The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma
|The American Journal of Surgical Pathology|2020|705
A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway Alterations
|Cancer Cell|2017|656
Widespread deregulation of microRNA expression in human prostate cancer
|Oncogene|2007|635